Trials / Completed
CompletedNCT00644982
A Comparison of Sertraline Versus Venlafaxine XR in the Treatment of Major Depression
A Multicenter Randomized, Double-Blind, Parallel-Group Study of Sertraline Versus Venlafaxine XR in the Acute Treatment of Outpatients With Major Depressive Disorder
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 163 (actual)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To assess the comparative efficacy of sertraline versus venlafaxine XR on measures of quality of life.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | sertraline | Flexibly-titrated 50 mg tablets, 50-150 mg/day and venlafaxine placebo orally for 10 weeks. |
| DRUG | venlafaxine XR | Flexibly-titrated 75 mg capsules, 75-225mg/day and sertraline placebo orally for 10 weeks. |
Timeline
- Start date
- 2002-10-01
- Completion
- 2003-09-01
- First posted
- 2008-03-27
- Last updated
- 2021-01-27
Locations
14 sites across 2 countries: Australia, Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT00644982. Inclusion in this directory is not an endorsement.